SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Dec-23 8:20 PM View: | Iteos Therapeutics, Inc. (ITOS) | 05-Dec-23 | Grant | 30,000 | -- | -- | 104% 28.9K to 58.9K | |
19-Apr-22 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 18-Apr-22 | Option Exercise | 11,500 | $4.23 | $48,645.00 | 44% 26.26K to 37.76K | |
19-Apr-22 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 18-Apr-22 | Option Sale | 11,500 | $31.87 | $366,530.00 | (30%) 37.76K to 26.26K | |
22-Mar-22 8:05 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Mar-22 | Sale (Planned) | 18,437 | $34.17 | $629,987.00 | (41%) 44.7K to 26.26K | |
14-Mar-22 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 11-Mar-22 | Grant | 10,000 | -- | -- | 29% 34.7K to 44.7K | |
24-Feb-22 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Feb-22 | Sale (Planned) | 14,500 | $34.34 | $497,905.00 | (29%) 49.2K to 34.7K | |
26-Jan-22 7:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 25-Jan-22 | Sale (Planned) | 14,500 | $35.68 | $517,378.00 | (23%) 63.7K to 49.2K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Dec-21 | Option Exercise | 1,663 | $4.30 | $7,150.90 | 2% 78.2K to 79.86K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Dec-21 | Market Option Sale (Planned) | 1,663 | $45.03 | $74,891.90 | (2%) 79.86K to 78.2K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Dec-21 | Market Sale (Planned) | 14,500 | $45.03 | $652,996.00 | (19%) 78.2K to 63.7K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 21-Dec-21 | Option Exercise | 19,226 | $4.30 | $82,671.80 | 25% 78.2K to 97.43K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 21-Dec-21 | Market Option Sale (Planned) | 19,226 | $44.41 | $853,906.00 | (20%) 97.43K to 78.2K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 20-Dec-21 | Option Exercise | 9,111 | $4.30 | $39,177.30 | 12% 78.2K to 87.31K | |
22-Dec-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 20-Dec-21 | Market Option Sale (Planned) | 9,111 | $43.94 | $400,337.00 | (10%) 87.31K to 78.2K | |
24-Nov-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Nov-21 | Market Option Sale (Planned) | 14,500 | $36.08 | $523,160.00 | (16%) 92.7K to 78.2K | |
24-Nov-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Nov-21 | Option Exercise | 16,263 | $12.45 | $202,474.00 | 21% 76.44K to 92.7K | |
03-Nov-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 03-Nov-21 | Market Sale (Planned) | 6,085 | $28.89 | $175,777.00 | (7%) 82.52K to 76.44K | 1% |
03-Nov-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 02-Nov-21 | Market Sale (Planned) | 14,391 | $28.42 | $408,920.00 | (15%) 96.91K to 82.52K | (< 1%) |
03-Nov-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 01-Nov-21 | Market Sale (Planned) | 81 | $28.00 | $2,268.00 | (< 1%) 96.99K to 96.91K | (2%) |
25-Oct-21 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 21-Oct-21 | Market Sale (Planned) | 196 | $28.00 | $5,488.02 | (< 1%) 97.19K to 96.99K | 2% |
19-Oct-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 19-Oct-21 | Market Sale (Planned) | 201 | $28.00 | $5,628.00 | (< 1%) 97.39K to 97.19K | 1% |
19-Oct-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 15-Oct-21 | Market Sale (Planned) | 1,635 | $28.01 | $45,796.40 | (2%) 99.03K to 97.39K | 1% |
27-Sep-21 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 24-Sep-21 | Market Sale (Planned) | 1,089 | $28.02 | $30,511.60 | (1%) 100.11K to 99.03K | 3% |
27-Sep-21 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Sep-21 | Market Sale (Planned) | 5,322 | $28.16 | $149,862.00 | (5%) 105.44K to 100.11K | 4% |
03-Sep-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 02-Sep-21 | Market Sale (Planned) | 11,568 | $28.94 | $334,796.00 | (10%) 117.0K to 105.44K | 6% |
03-Sep-21 8:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 01-Sep-21 | Market Sale (Planned) | 8,684 | $28.30 | $245,722.00 | (7%) 125.69K to 117.0K | 4% |
31-Aug-21 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 31-Aug-21 | Market Sale (Planned) | 4,093 | $28.12 | $115,095.00 | (3%) 129.78K to 125.69K | 3% |
31-Aug-21 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 30-Aug-21 | Market Sale (Planned) | 2,322 | $28.01 | $65,039.20 | (2%) 132.1K to 129.78K | 3% |
31-Aug-21 8:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 27-Aug-21 | Market Sale (Planned) | 8,248 | $28.17 | $232,346.00 | (6%) 140.35K to 132.1K | 4% |
25-Aug-21 8:04 PM View: | Iteos Therapeutics, Inc. (ITOS) | 25-Aug-21 | Market Sale (Planned) | 861 | $28.00 | $24,109.10 | (< 1%) 141.21K to 140.35K | 3% |
25-Aug-21 8:04 PM View: | Iteos Therapeutics, Inc. (ITOS) | 24-Aug-21 | Market Sale (Planned) | 225 | $28.26 | $6,358.50 | (< 1%) 141.44K to 141.21K | 4% |
25-Aug-21 8:04 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Aug-21 | Market Sale (Planned) | 7,499 | $28.06 | $210,422.00 | (5%) 148.94K to 141.44K | 3% |
16-Jun-21 6:48 PM View: | Iteos Therapeutics, Inc. (ITOS) | 14-Jun-21 | Market Sale (Planned) | 29,000 | $28.50 | $826,534.00 | (16%) 177.94K to 148.94K | 5% |